Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Polycythemia Vera
|
38 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.900 | 0.960 | 274 | 2005 | 2019 | |||||
Leukemia, Myelocytic, Acute
|
6892 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.900 | 0.966 | 29 | 2005 | 2019 | |||||
Myeloproliferative disease
|
43 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.800 | 0.970 | 263 | 2005 | 2019 | |||||
Primary Myelofibrosis
|
29 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.800 | 0.966 | 175 | 2005 | 2020 | |||||
THROMBOCYTHEMIA 3
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.800 | 1.000 | 2 | 2005 | 2012 | |||||
Budd-Chiari Syndrome
|
4 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.770 | 0.900 | 10 | 2006 | 2016 | |||||
Polycythemia
|
22 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.750 | 1.000 | 5 | 2006 | 2012 | |||||
Erythrocytosis familial, 1
|
14 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.710 | 1.000 | 1 | 2008 | 2008 | |||||
Serum total cholesterol measurement
|
1243 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 1.000 | 2 | 2017 | 2018 | |||||
High density lipoprotein measurement
|
1440 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||
BUDD-CHIARI SYNDROME, SUSCEPTIBILITY TO, SOMATIC
|
1 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 0 | ||||||||
Splenomegaly
|
19 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.700 | 0 | ||||||||
Chronic myeloproliferative disorder
|
47 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.974 | 269 | 2005 | 2020 | |||||
Thrombocythemia, Essential
|
37 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.982 | 222 | 2005 | 2020 | |||||
Myelofibrosis
|
7 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.944 | 72 | 2005 | 2019 | |||||
Thrombocytosis
|
12 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.920 | 25 | 2006 | 2018 | |||||
Neoplasms
|
1644 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 1.000 | 21 | 2007 | 2019 | |||||
Myeloid Leukemia, Chronic
|
115 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.889 | 18 | 2008 | 2019 | |||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.929 | 14 | 2005 | 2018 | |||||
Malignant Neoplasms
|
1641 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 1.000 | 13 | 2006 | 2018 | |||||
Leukocytosis
|
4 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 0.818 | 11 | 2006 | 2017 | |||||
leukemia
|
144 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.100 | 1.000 | 10 | 2006 | 2017 | |||||
Leukemia, Myelomonocytic, Chronic
|
28 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.080 | 1.000 | 8 | 2005 | 2019 | |||||
Neoplasm, Residual
|
23 | 0.458 | 0.760 | 9 | 5073770 | missense variant | G/A;T | snv | 3.5E-04 | 0.080 | 1.000 | 8 | 2007 | 2016 |